Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commotio cordis…once again: Unusual occurrence in a noncontact sport.

HeartRhythm case reports·2024
Same author

Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Circulation·2023
Same author

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity.

Heart rhythm O2·2023
Same author

QRS Fragmentation as a Risk Marker for Sudden Death in Hypertrophic Cardiomyopathy.

JACC. Clinical electrophysiology·2023
Same author

Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.

Journal of the American College of Cardiology·2023
Same author

Commotio Cordis Returns…When We Least Expected It: Cardiac Arrest in A Professional Football Player.

The American journal of cardiology·2023
Same journal

Green Heart: Methylene Blue administration in a hemodynamically unstable infant following cardiac arrest due to parental co-sleeping.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Adventitial Melanocytosis ("Blue nevus") of the Aorta.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Lipomatous Hamartoma of the Semilunar Valve Exhibits Molecular Genetic Characteristics of Lipoma.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Proteomic profiling of whole tissue sections in cardiac ATTR amyloidosis reveals increased extracellular matrix remodeling.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Burden of cardiovascular disease in victims of fatal intoxication: An autopsy study.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Can sudden cardiac death be prevented?

Barry J Maron1

  • 1Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA. hcm.maron@mhif.org

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|April 10, 2010
PubMed
Summary
This summary is machine-generated.

Implantable cardioverter-defibrillators offer proven protection against sudden cardiac death in hypertrophic cardiomyopathy patients. Identifying candidates requires careful risk assessment and physician judgment for effective prophylactic therapy.

More Related Videos

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Related Experiment Videos

Last Updated: Jun 14, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Area of Science:

  • Cardiology
  • Genetics
  • Preventive Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young individuals, including athletes.
  • Implantable cardioverter-defibrillators (ICDs) represent a significant advancement in managing HCM, offering protection against SCD.
  • The heterogeneity of HCM and challenges in risk stratification complicate the selection of appropriate candidates for prophylactic ICD therapy.

Purpose of the Study:

  • To evaluate the role and challenges of implantable cardioverter-defibrillators in preventing sudden cardiac death in hypertrophic cardiomyopathy.
  • To discuss the current strategies for identifying high-risk patients eligible for prophylactic ICD implantation.
  • To highlight the impact of ICDs on the natural history and longevity of hypertrophic cardiomyopathy patients.

Main Methods:

  • Review of current clinical practice and risk stratification algorithms for hypertrophic cardiomyopathy.
  • Analysis of the effectiveness of implantable cardioverter-defibrillators in terminating life-threatening arrhythmias.
  • Consideration of challenges in prospective, randomized trials for prophylactic ICD therapy in HCM.

Main Results:

  • Implantable cardioverter-defibrillators are the only proven method to terminate ventricular tachycardia/fibrillation, thus preventing sudden death in HCM.
  • Despite complexities in risk stratification, a combination of risk factor algorithms and physician judgment effectively identifies high-risk patients.
  • ICDs alter the natural history of HCM, offering potential for normal longevity in many patients.

Conclusions:

  • Prophylactic ICD implantation is a crucial, though challenging, component of hypertrophic cardiomyopathy management.
  • Effective identification of at-risk individuals is paramount for successful ICD therapy.
  • ICDs have transformed the prognosis for many patients with hypertrophic cardiomyopathy, reducing mortality from sudden cardiac death.